Find eligible patients that fit your protocol faster, identify and secure proven and/or new sites, forecast and measure progress more efficiency. With Covance's proprietary data, your program hits its mark.

1. REAL-TIME
REAL-WORLD
SEE THE REAL-WORLD
IMPACT FOR YOURSELF.
WE DON’T
JUST TALK
ABOUT DATA.
WE SHOW
RESULTS.

2. A DIRECT CONNECTION TO FINDING POTENTIAL
CLINICAL TRIAL PARTICIPANTS
CLIENT CHALLENGE
CLIENT CHALLENGE
REAL-WORLD IMPACT
REAL-WORLD IMPACT
Month 1 Results: 4,829 patients emailed, 523 visited the study website, 7 consented, 6 completed
Patient Service Center (PSC) blood draws
Difficulty recruiting
patients for a virtual
study with a PSC
blood draw
Extremely tight
turnaround times
for launching email
campaigns and
boosting recruitment
PROTOCOL DESIGN TO MAXIMIZE
PATIENT ENROLLMENT OPPORTUNITY
Result: The eligible patient population increased by +50% without compromising the objectives of the trial.
Analyzed LabCorp de-identified
clinical laboratory data to discern
whether small protocol changes
could accelerate recruitment.
Data helped to identify that
making minor changes to the
eGFR cutoff would increase
the patient pool size, therefore
reducing recruitment timelines.
Study to test if a drug
reduced progression of
kidney disease in patients
with Type II diabetes
Study was looking for a
small subset of patients
which represented
<7% of patients
Leveraged LabCorp
database to find potential
patients in key geographies
as specified by the client.
LabCorp sent emails with
study specific website
links to targeted patient
populations.
Seeking patients with
a history of stroke or
cardiovascular event
~150 Million
Lives
>150
million patients
>30
billion test results
>

3. INCORPORATING THE PATIENT VOICE
CLIENT CHALLENGE
CLIENT CHALLENGE REAL-WORLD IMPACT
REAL-WORLD IMPACT
Result: Conducted research with 320 Ulcerative Colitis patients to design a study to meet the client’s
needs. Extended the known investigator database for Ulcerative Colitis with available capacity.
Leveraged Covance Patient
Intelligence Database to
improve patient recruitment
and retention rates.
Identified investigator best-
suited to run Ulcerative
Colitis studies with available
capacity.
Limited patient population
due to competing studies
and the fact that 90% of
patients don’t participate
in clinical trials
Difficulty finding, productive
investigators for study in a
highly competitive space
EXCEEDING RECRUITMENT GOALS FOR A
GLOBAL MULTI-STUDY REGISTRATION PROGRAM
Result: Achieved “first patient in” (FPI) requirement ahead of schedule for all studies in the program.
Beat historical industry performance across a number of key metrics:
18% fewer weeks from final protocol to FPI | 75% more high-performing sites
31% more patients/site/month | 41% fewer non-performing sites
Randomize 2,700
patients within a very
narrow timeframe for
a suite of registration
studies
Get all sites across
the globe up and
running as quickly
as possible
Leveraged Xcellerate®
historical investigator
database to identify and
secure highest performing
investigators in indication.
Based on extensive feasibility
outreach and site capacity
assessment, efficiencies
were identified that allowed
effective overlapping of sites
across the program resulting in
accelerated site start-up and
reduced clinical costs.
90%
~30countries
>20
indications
>175k
unique investigators
>15k
protocols

4. *Average time savings based on an analysis of trials processed through Covance Central Labs with Protocol
Finalization date after 1/1/2009 for the specific clinical indications. Past performance is not a guarantee of
future results, and a variety of factors other than CRO performance can impact timing of clinical studies.
Covance is the drug, medical device and diagnostics
business segment of LabCorp, a leading global
life sciences company. COVANCE is a registered
trademark and the marketing name for Covance Inc.
and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623)
+1.609.452.4440
Europe/Africa +00.800.2682.2682
+44.1423.500888
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2019 Covance Inc. BROCVD018-1019
REAL-TIME DATA. REAL-WORLD IMPACT.
Talk to a representative to find out how Covance can impact your studies.
LEARN MORE AT COVANCE.COM/REALIMPACT
COVANCE DATA CAN HELP ACCELERATE YOUR STUDIES.
Covance data is comprised of four powerful data sets: LabCorp De-Identified Lab Result Data,
Covance Central Labs Investigator Data, Patient Direct and Patient Intelligence. The combination of
these data sets provides unique insights, enabling us to deliver strong, viable protocol designs for
faster patient enrollment, more patients per site and fewer non-performing sites than the industry
average. By increasing forecast accuracy, you can minimize study costs and speed time to market.
SITE ACTIVATION TO LAST PATIENT IN
Number of Months*
MONTHS
FASTER
CARDIOVASCULAR3.1 MARKET
12.92
MONTHS
COVANCE
9.85
MONTHS
5.0
MARKET
14.88
MONTHS
COVANCE
9.94
MONTHS
MONTHS
FASTER
NEUROLOGY
3.3 MARKET
18.66
MONTHS
COVANCE
15.41
MONTHS
MONTHS
FASTER
HEMATOLOGY
4.2 MARKET
20.99
MONTHS
COVANCE
16.80
MONTHS
MONTHS
FASTER
ONCOLOGY